SP Industries acquires PennTech Machinery Corporation
Penntech is a global provider of complete vial handling solutions covering washing, sterilization, filling, stoppering, capping and both tray and freeze dryer loading/unloading equipment.
SP Industries, a leading designer and manufacturer of state-of-the-art laboratory equipment, research, pilot and production freeze dryers, laboratory supplies and glassware has acquired the assets of privately held PennTech Machinery Corporation.
Penntech is a global provider of complete vial handling solutions covering washing, sterilization, filling, stoppering, capping and both tray and freeze dryer loading/unloading equipment, located in Warminster (PA, USA).
“PennTech has a well-earned reputation for producing high quality, often customized, equipment and is the only US-based manufacturer to offer complete aseptic processing lines,” stated SP CEO Bill Downs. “As a leading supplier to the pharmaceutical, biotech and scientific markets, SP is continually focused on bringing value to our customer relationships. PennTech’s current portfolio, engineering expertise and broad capabilities around liquid vial handling are a very strategic complement to our Hull and VirTis pilot and production freeze dryer lines, allowing us to offer a complete suite of manufacturing solutions for semi-automated to fully automated drug production environments.”
Downs continued by saying: “We are excited to establish PennTech as a flagship brand within our SP Scientific equipment division. Key manufacturing, engineering, sales and service personnel from PennTech have joined the SP team to assure continuity in operations and service. Vincent Smit, who had served as CEO of PennTech, will play a significant role in sales and product development projects and we look forward to benefiting from his vision and depth of knowledge.“
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance